期刊文献+

不同剂量布地奈德混悬液雾化吸入治疗小儿毛细支气管炎疗效观察 被引量:9

Comparison study on the efficacy of bronchiolitis between different dosage of nebulised Budesonide Suspension for Inhalation
暂未订购
导出
摘要 目的观察不同剂量布地奈德混悬液雾化吸入治疗小儿毛细支气管炎的临床疗效。方法对分别给予布地奈德混悬液0.5mg/次(低剂量组)与1mg/次(高剂量组)雾化吸入治疗的80例毛细支气管炎患儿的临床资料进行分析比较。结果①1mg组30、60分钟临床评分显著低于0.5mg组,差异有统计学意义(P<0.01或P<0.001)。②1mg组30、60分钟呼吸频率显著低于0.5mg组,差异有统计学意义(P<0.01或P=0.05)。③1mg组30、60分钟氧饱和度显著高于0.5mg组,差异有统计学意义(P<0.001或P<0.01)。④1mg组平均住院时间、平均住院费用显著低于0.5mg组,差异有统计学意义(P<0.001)。⑤1mg组与0.5mg组雾化吸入均无明显不良反应。结论 1mg布地奈德混悬液雾化吸入治疗小儿毛细支气管炎与0.5mg相比,更能显著降低患儿在吸入治疗后30、60min的临床评分、呼吸频率,改善患儿氧饱和度,并缩短患儿的住院时间,降低住院费用。患儿雾化吸入布地奈德治疗无明显不良反应。 Objective To evaluate the clinical feature of pediatric patients with bronehiolitis, and compare their treatment response between different dosage of nebulised Budesonide Suspension for Inhalation. Methods The data of the children diagnosed and administrated between 2011.1-2011.5 were collected and analyzed by soft ware SPSS 19.0. The patients were randomly divided into 0. 5mg group(nebulised Budesonide Suspension for Inhalation 0.5mg once)and lmg group(nebulised Budesonide Suspension for Inhalation ling once). The clinical score,respiratory frequency,oxygen saturation, length of stay, the cost were evaluated. Results 30 minutes after the treatment, The clinical score in ling group(6. 28± 1.16)was statistically lower than that(6.91±1.03) in the 0.5mg group(P= 0. 007), the respiratory frequency in lmg group(55.7±7.1)was statistically lower than that(60. 23±6.2)in the 0. 5mg group(P=0. 003), the oxygen saturation in lmg group ( 96.7 ±2.5 %) was statistically higher than that ( 94.3 ±1.8 %) in the 0. 5mg group (P〈0. 001 ). 60 minutes after the treat, The clinical score in 1 mg group(5.14±1.58) was statistically lower than that(6.25.± 1.37) in the 0. 5rag group(P'(0. 001), the respiratory frequency in lmg group(51.5 ±7. 3)was statistically lower than that(55.3d: 6.4) in the 0. 5mg group(P= 0. 016), the oxygen saturation in lmg group(97.2 ± 2. 6%) was statistically higher than that(95.6±2.3 % )in the 0. 5mg group (P= 0. 004)the length of stay in l mg group(6.42±1.89) was statisti- cally shorter than that(8. 71±2.53) in the 0.5mg group(P〈0. 001), the cost of hospitalization in lmg group(2142±164%)was statistical cheaper than that(2573-+-189±)in 0.5mg group(P〈0. 001). Conclusion The treatment response of the patients with bronchiolitis in ling group are better than that in 0.5mg group, These include faster changing in clinical score,respiratory frequency, oxygen saturation; shorter hospital day and less cost.
作者 刘巧 刘小芸
机构地区 德阳市人民医院
出处 《西部医学》 2013年第5期681-684,共4页 Medical Journal of West China
关键词 布地奈德混悬液 毛细支气管炎 疗效 different dosage Budesonide Suspension for Inhalation Bronchiolitis efficacy
  • 相关文献

参考文献13

  • 1Leader S,Kohlhase K. Recent trends in severe respiratory syn-cytial virus (RSV)among US infants, 1997 to 2000[J]. J Pedi-atr, 2003, 143:S127 - S132.
  • 2Njoo H. Pelletier L. Spika J. Infectious diseases. In: CanadianInstitute for Health Information, Canadian Lung Association,Health Canada. Statistics Canada. eds. Respiratory disease inCanada[M]. Ottawa: Canadian Institute for Health Informa-tion, 2001:81-86.
  • 3Shay DK, Holman RC. Newman RDtetal. Bronchiolitis associ-ated hospitalizations among US children, 1980-1996 [J]. JA-MA, 1999,282; 1440-1446.
  • 4Pelletier AJ, Mansbach JM, Camargo CA Jr. Direct medicalcosts o. bronchiolitis hospitalizationsin the United States[J].Pediatrics,2006,118(6) :2418-2423.
  • 5Hall CB, Weinberg GA, Iwane MK, et al. The burden of re-spiratory syncytial virus infection in young children[J]. N EnglJ Med, 2009, 360(6),588-598. PMID: 19196675.
  • 6Bentur L. Shoseyov D,Feigenbaum D, et al. DexamethasoneInhalations in RSV bronchiolitis: a doublebiind, placebo-con-trolled study[J]. Acta Paediatr, 2005, 94:866-871.
  • 7Hartling L,Wiebe N, Russell K, et al. A meta-analysis of ran-domized controlled trials evaluating the efficacy of epinephrinefor the treatment of acute viral bronchiolitis [J3. Arch PediatrAdolesc Med, 2003,157:957-964.
  • 8申昆玲,李云珠,李昌崇,刘恩梅,陈育智,陈志敏,俞善昌,洪建国,赵德育,盛锦云,鲍一笑.糖皮质激素雾化吸入疗法在儿科应用的专家共识[J].临床儿科杂志,2011,29(1):86-91. 被引量:238
  • 9胡亚美 江载芳 诸福棠.实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1900.
  • 10Beck R. Elias N computerized acoustic assessment of treatmentefficiency of nebulized epinephrine and albuterol in RSV bronchi-olitis [J]. J BMC Pediatr, 2007,7(1):22-27.

二级参考文献35

  • 1张远清,何颜霞,林荣枢.普米克令舒雾化吸入治疗小儿气管插管导致的喉头水肿[J].实用医学杂志,2006,22(23):2787-2788. 被引量:13
  • 2Global Initiative for Asthma.Global Strategy for Asthma Diagnosis and Prevention.Global Initiative for Asthma(updated 2008)[EB/OL].[2010-11-04] http://www.ginasthma.org/download.asp?intld=343.
  • 3Global Initiative for Asthma.Global Strategy for Asthma Diagnosis and Prevention.Global Initiative for Asthma(updated 2009)[EB/OL].[2010-11-04] http://www.ginasthma.com/download.asp?intld = 411.
  • 4洪建国.吸入装置的研究进展[M] //林江涛,殷凯生.哮喘防治新进展专题笔谈.北京:人民卫生出版社,2008:206-216.
  • 5Sbirlea-Apiou G,Katz I,Caillibotte G,et al.Deposition mechanics of pharmaceulical particles in human airways[M] //Hickey AJ.Inhalation Aerosols.New York:Informa Healthcare USA,2007:1-30.
  • 6Hess DR.Nebulizers:principles and performance[J].Respir Care,2000,45(6):609-622.
  • 7Dolovich MB,Ahrens RC,Hess DR,et al.Device selection and outcomes of aerosol therapy:evidence-based guidelines:American College of Chest Physicians/American College of Asthma,Allergy,and Immunology[J].Chest,2005.127(1):335-371.
  • 8Song IH,Buttgereit F.Non-genomic glucocorticoid effects to provide the basis for new drug developments[J].Mol Cell Endocrinol,2006,246(1-2):142-146.
  • 9Nuhoglu Y,Atas E,Nuhoglu C,et al.Acute effect of nebulized budesonide in asthmatic children[J].J Investig Allergol Clin Immunol,2005,15(3):197-200.
  • 10Desai D,Brightling C.Cough due to asthma,cough variant asthma and non-asthmatic eosinophilic bronchitis[J].Otolaryngol Clin North Am,2010,43(1):123-130.

共引文献809

同被引文献83

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部